Skip to content

Ear-acupuncture therapy for epilepsy

Ear-acupuncture therapy for epilepsy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001023
Enrollment
Unknown
Registered
2010-09-30
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Treatment group:acupuncture on auricular non-acupoints with 1mA electric needle for 30min, three times a day. Treatment lasts for 24 weeks.
Control group:acupuncture on auricular non-acupoints with 1mA electric needle for 30min, three times a day. Treatment lasts for 4 weeks. Then patients will be transfered to treatment group if no effec

Sponsors

China Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged 12 to 65 yrs old; 2. Patients meeting the diagnosis of partial epilepsy according to Classification of epilepsay issued by International league against epilepsy, 1981), who get no remission after following routine antiepileptics treatment for 1 year or more; 3. The seizure attacked over 4 times per month within 8 weeks before recruitment; 4. Patients are receiving at least one type of antiepileptics, and have no change in medication within 8 weeks before recruitment; 5. No brain tumor, progressive brain disease or neural degeneration confirmed by EEG within 6 months or by previous MRI or CT scan; 6. No other somatic disease and can count the frequency of seizure attack; 7. women at reproductive age have take effective contraceptive interventions.

Exclusion criteria

Exclusion criteria: 1. Patients with CNS disease; 2. Non-epileptic seizures or pseudoeilepsy; 3. Patients with history of status Epilepticus or cluster seizures; 4. Patients with severe mental retardation or unstable mental state; 5. Patients with severe heart, liver, kidney disease or hematologic disease; 6. Women undergoing pregnancy or lactation; 7. Patients have enrolled in other antiepileptics trial within 8 weeks before recruitment; 8. Patients have implanted stimulator of the Cervical Vagus Nerve; 9. Patients with poor compliance.

Design outcomes

Primary

MeasureTime frame
Frequency of epilepsy attach;

Countries

China

Contacts

Public ContactPeijing Rong
rongpj@hotmail.com+86 10 64014411 2774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 8, 2026